Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Clinical trial NCT00040144 · TERMINATED
Trial details
- NCT number
- NCT00040144
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.